Immunoassay Market PowerPoint PPT Presentations

Immunoassay Interference Blocker Market Segmented Antibody Interference Blockers, Detection Interference Blockers, Surface Interference Blockers Product in Sandwich Immunoassays, Antibody Capture Assays, Competitive ELISA Application

The global immunoassay market is driven by technological advancements in the development of new immunoassays and analyzers and demographic and life changes favoring rapid, preventive, and predictive diagnosis.

The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements.

Chemiluminescence immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true ?indicator? of the analytic reaction, is a luminescent molecule. CLIA instruments progressively infiltrated the immunometric assay domain, eventually being used to measure serum concentrations of hormones, drugs, vitamins, tumour markers, infectious disease markers, myocardial damage markers and, finally, autoantibodies. Today, autoantibody detection in immunochemiluminescence can be carried out on instruments specifically dedicated to the autoimmunology laboratory as stand-alone instrumentation or as part of an automated analytical platform.

An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody (usually) or an antigen (sometimes).

The improvement in food safety regulations, rapid advancement in automation of food testing protocols, increasing occurrence of food borne illness, growing demand of the packaged and organic food products will accelerate the growth of molecular methods market in the forecast period of 2020-2027.. On the other hand, rise in the cost of advanced molecular testing equipment and lack of food safety awareness in emerging economies will hamper the growth of the market in the above mentioned forecast period.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering BioRad Siemens Healthcare

The global multiplex detection immunoassay market is set to be valued at over US$ 2 Bn by 2019 end, with the market expected to exhibit a healthy CAGR during the forecast period (2019 – 2029).

On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period.

The global multiplex detection immunoassay market is set to be valued at over US$ 2 Bn by 2019 end, with the market expected to exhibit a healthy CAGR during the forecast period (2019 – 2029).

The demand for point-of-care testing under home care settings is expected to drive the Lateral Flow Immunoassay (LFIA) Based Rapid Test market.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, reports on various segments by type, geography, growth, and competitive landscape - says TBRC. http://bit.ly/385hzrm

Global Immunoassay Analyzers Market 2019 by Size, Device, Indication, and Prominent Players| Analysis, Regional Growth, Demand and Business Opportunities

Chemiluminescent immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true “indicator” of the analytic reaction, is a luminescent molecule. North America is the largest consumption place, with a consumption market share nearly 38.2% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 28.7%.

According to latest research by PMR, the global immunoassay interference blocker market is estimated to have accounted for ~ US$ 200.0 Mn in terms of value in 2018. The report on the immunoassay interference blocker market further projects that the immunoassay interference blocker market is likely to expand at a CAGR of ~ 7% during the period 2019-2029.

Big Market Research added a new survey on "2015 Opportunities in the Herpes Markers Diagnostic Testing Market" Download The Complete Report On : http://www.bigmarketresearch.com/2015-opportunities-in-the-herpes-markers-diagnostic-testing-market The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed

The global multiplex detection immunoassay market is set to be valued at over US$ 2 Bn by 2019 end, with the market expected to exhibit a healthy CAGR during the forecast period (2019 – 2029).

Big Market Research added a new package "2015 Opportunities in the Hepatitis Markers Diagnostic Testing Market" to its list Access The Full Report On : http://www.bigmarketresearch.com/2015-opportunities-in-the-hepatitis-markers-diagnostic-testing-market The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.

Get more details @ http://bit.ly/2sK8r9n Some of the prominent Automated Immunoassay Analyzers industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.

Global Fluorescence Polarization Immunoassay Analyzer Market Research Report 2017

Get more details @ http://bit.ly/2sK8r9n Some of the prominent Automated Immunoassay Analyzers industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.

Major Players in the Lateral Flow Immunoassay (LFIA) Based Rapid Test Market are Abbott Laboratories, F. Hoffmann-La Roche, Danaher Corporation, Siemens AG, Becton, Dickinson and Company Read More @ https://bit.ly/33Yq7jC

Avail more information from Sample Brochure of report @ http://goo.gl/JbJksM The “2016-2020 World Papillomavirus Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts” report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. Read analysis @ http://goo.gl/Kjkmai

The global rapid influenza diagnostic tests market size will witness robust expansion at over 8% CAGR during the forecast period (2019 – 2029).

Avail more information from Sample Brochure of report @ http://goo.gl/H8SS1O The “2016-2020 World Mycoplasma Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts” report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. Read analysis @ http://goo.gl/Vx90LH

In this report, the global IVD market is segmented by products & services, technology, application, end user, and region. Based on technology, the IVD market is mainly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The immunoassays/immunochemistry segment accounted for the largest share of the IVD market in 2015. The growing preference for these technologies in clinical diagnostics over conventional methods and the ability of immunoassay/immunochemistry technologies to offer faster results with high sensitivity and accuracy are contributing to the growth of immunoassays/immunochemistry market during forecast period.

In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017.

Big Market Research | Noninvasive Cancer Diagnostics and Technologies Market | Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013.

Immunoassay Analyzers Market Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023

Food Testing Market shall witness 8.4% CAGR growth until 2018 owing to the increased number of tests that will be conducted. According to IndustryARC, Food Testing Market which includes the food safety testing market is expected to grow at a healthy growth rate of around 6% during the forecast period until 2018.

This new 247-page report provides a comprehensive analysis of the French Therapeutic Drug Monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin. Complete report is available @ http://www.reportsnreports.com/reports/274303-2014-strategies-for-the-french-therapeutic-drug-monitoring-tdm-market.html .

Download Sample Brochure @ http://goo.gl/tWKyQ6 The “2016-2020 World Rabies Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts” report presents a detailed analysis of the Rabies diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rabies definition, epidemiology and etiology are reviewed. Read analysis @ http://goo.gl/jm4GXB

Avail more information from Sample Brochure of report @ http://goo.gl/wRLypE The “2016-2020 World H. Pylori Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts” report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. Check complete report @ http://goo.gl/A5trdI

Big Market Research added a new research report package on "2015 World Tumor Marker and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan" Access The Full Report On : http://www.bigmarketresearch.com/2015-world-tumor-marker-and-special-chemistry-testing-us-europe-france-germany-italy-spain-uk-japan-market This new 320-page report contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

Radio immunoassay (RIA) reagents and devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 3.52% in the above-mentioned forecast period.

Big Market Research : Japanese Microbiology Testing Market : Trends, Size, Supplier Shares and Country Forecasts 2014 To Get More Details @ http://www.bigmarketresearch.com/future-horizons-and-growth-strategies-in-the-japanese-microbiology-testing-2014-supplier-shares-and-country-forecasts-market This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

To Get sample Brochure now@ http://tinyurl.com/z5hlh4y A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Food Diagnostic Equipment and Consumables Market and future opportunities are provided in the report.

The global endocrine testing market was valued at US$6 billion in 2014 and is estimated to reach near about US$13 bn by 2023 at a CAGR of 8.8% from 2015 to 2023.

Big Market Research has announced a new Report Package " Immunoassay Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/european-microscopy-mnm-market The immunoassay market is expected to reach $23,712.4 million by 2019 from $14,926.3 million in 2014, at a CAGR of 9.7% from 2014 to 2019. This market is categorized on the basis of technology, products and services, applications, end users, and regions. Based on products and services, the immunoassay market is categorized into analyzers, reagents and kits, and software and services. Enquire About this report at: http://www.bigmarketresearch.com/report-enquiry/280871

The global market for food additives testing has been segmented by the type of additives and type of technologies. The important food additives testing technologies include PCR-based testing, immunoassay-based testing, convenience-based testing and others

Meat Testing Market categorises the global market by Technology (Spectroscopy, PCR, Immunoassay, Chromatography), Target Tested (Allergen, GMO, Veterinary Drug Residue, Pathogen, Species, Mycotoxin, Heavy Metal), Sample (Meat and Seafood), and Region

China In Vitro Diagnostics Market will be USD 22.3 Billion by 2026. Forecast by Segment (Clinical Chemistry, Immunoassay, Molecular Testing, Microbiology, Hematology, SMBG, Point of Care Testing, Coagulation), Company Analysis.

Food diagnostic equipment and consumable market is valued 3316$ million in the year 2017 and is anticipated to grow at a CAGR of 5.9% from 2018-2023. Food diagnostic equipment and consumable market is segmented based on the testing equipment’s available in which PCR equipment is having high market share which is valued 853$ million in the year 2017 and is expected to grow at a CAGR of 7.4% between 2018-2023 and followed by immunoassay system which is valued 721$ million in the year 2017 and is expected to grow at a CAGR of 6.8% from 2018-2023. The rising concern over food quality and safety will increase the market size of food diagnostics equipment market.

Allergy diagnostics can be segmented on the basis of the different types of product such as assay kits, consumables which comprise of the luminometers and the immunoassay analysers and many more. It helps in the identification of the nature and treatment used in allergy diagnosis. The report from IndustryARC gives an in-depth analysis and segmentation of the global allergic diagnostics market. Pricing analysis and value chain analysis will give key insights into the value addition as well as the market pricing scenario. Forecasts are provided for all the market segmentations for the period 2015 -2020. Request for TOC @ http://bit.ly/2Akq7bp

Big Market Research has announced a new Diagnostic and Biotech market report “2015 Opportunities in the Global HIV/AIDS Diagnostic Testing Market”.This Report Offers Global HIV/AIDS Diagnostic Testing Market-DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles,Report and Research 2015. To Get More details Here @ http://www.bigmarketresearch.com/2015-opportunities-in-the-global-hiv-aids-diagnostic-testing-market The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIV Ag, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets: Enquire About Report Here@ http://www.bigmarketresearch.com/report-enquiry/200029

The residue testing market is projected to reach USD 4.41 billion by 2021 at a CAGR of 6.4% from 2016. The market is driven by factors such as increase in outbreaks of chemical contamination in food processing industries VISIT HERE @ https://www.grandresearchstore.com/agriculture-industry/residue-testing-market-by-type-pesticides-toxins-heavy-metals-allergens-technology-chromatography-spectroscopy-immunoassay-food-tested-meat-26-poultry-dairy-products-processed-food-fruits-26-vegetables-cereals---global-forecast-to-2021

Genetically Modified Food Safety Testing Market report categorizes the global market by Technology (Polymerase Chain Reaction, Immunoassay), Trait (Stacked, Herbicide Tolerance), & by Region.

On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015.

GMO Testing Market categorizes the global market by Trait (Stacked, Herbicide Tolerance, Insect Resistance), Technology (Polymerase Chain Reaction, Immunoassay), Crop Tested, Processed Food Tested, and Region

The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.

Empty Capsules Market by Product (Hard gelatin, Non-gelatin capsules), Raw Material (Pig meat, Bovine, HPMC), Therapeutic Application (Antibiotics, Vitamins) & by End User (Pharmaceutical, Health Supplements) - Global Forecast to 2019

Big Market Research added a new report "Infectious Disease Testing Market 2015: Strategic Assessments of Leading Suppliers" to their list Read The Complete Report On : http://www.bigmarketresearch.com/infectious-disease-testing-2015-strategic-assessments-of-leading-suppliers-market This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several others.

In Vitro Diagnostics Market by Technology (Point of Care, Molecular Diagnostics, Immunoassays, Clinical Chemistry, Whole Blood Glucose Monitoring, Hematology, Clinical Microbiology, and Coagulation and Hemostasis), Application (Drug Testing, Infectious Disease, Oncology, Metabolic Disease, and Autoimmune Disease), Geography and Forecast

The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026

Summary Big Market Research presents this 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. Read The Complete Report On : http://www.bigmarketresearch.com/2015-analysis-of-transfusion-diagnostic-technologies-and-strategic-profiles-of-leading-suppliers-market

Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Read more at: https://www.alliedmarketresearch.com/immunodiagnostics-market The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.